Small-molecule trkB agonists promote axon regeneration in cut peripheral nerves

If treatments with small-molecule trkB agonists, especially systemically, proved effective in enhancing axon regeneration in injured peripheral nerves, such a result could form the basis for the development of a unique treatment strategy for peripheral nerve injuries.